Ana içeriğe geç
Ms Amrita Mahal
Güven puanı 8/100

Ms Amrita Mahal

Speech And Language Therapy · United Kingdom

👤 2 yıllık deneyim

6,779+ Patients seen
2 Years in practice
11 Publications
1 Languages spoken

Hakkında

Ms Amrita Mahal is an Advanced Speech & Language Therapist with over 18 years of clinical postgraduate experience, recognised as a highly skilled specialist in her field. As an integral member of Schoen Clinic Chelsea's multidisciplinary team, she plays a key role in the diagnosis of neurodevelopmental conditions such as Autism Spectrum Disorder and supports individuals across a broad range of communication, voice, and swallowing impairments and disorders.
Her expertise spans both paediatric and adult speech, language, and communication therapy, with a particular focus on the advanced management of complex swallowing disorders (dysphagia). Dr Mahal’s work addresses a wide array of conditions, including traumatic brain injuries, stroke recovery, head and neck cancers, as well as neurodevelopmental and progressive neurological conditions like Parkinson’s Disease and Functional Neurological Disorders.
A specialist in advanced dysphagia management, she provides evidence-based assessments and treatments such as clinical bedside swallow evaluations and functional swallowing rehabilitation using techniques like the McNeil Dysphagia Therapy Program and IQoro therapy. Her deep understanding of the neurophysiology of swallowing ensures comprehensive support for individuals with eating and drinking difficulties.
In addition, Dr Mahal is an advanced practitioner in managing voice disorders. She offers specialised voice therapy, including certified training in the Lee Silverman Voice Treatment (LSVT) program, and utilises techniques such as laryngeal manipulation and myofascial release therapy to relieve tension and improve vocal function. She supports professional voice users experiencing voice changes or loss and provides expert care for chronic cough and voice impairment related to acid reflux or respiratory conditions. Moreover, she offers Trans Voice and Communication Therapy to help individuals in the transgender community achieve authentic vocal expression.

“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”

— Ms Amrita Mahal

Eğitim ve öğretim

  1. 2014–2020 MD · Medicine and Surgery
    Universidad de Navarra (GB)
  2. 2020–2024 Residency · Speech And Language Therapy
    Universidad de Navarra (GB)

Kariyer ve atamalar

  1. 2024-09–2025-08 Junior consultant
    Universidad de Navarra Teaching Hospital — Speech And Language Therapy

Lisanslar ve sigorta

Tıbbi lisanslar

GB — Organización Médica Colegial de España (OMC)
#GB-802839 active · expires 2028-12-31

Kurul sertifikaları

European Board of Speech And Language Therapy
#EB-91DE1DFD · issued 2025 · renewal 2035
Mesleki sorumluluk sigortası: AmTrust Europe · 5,000,000 EUR kapsam · No claims on file

Gerçekleştirilen prosedürler

ProsedürKodToplam sayı
GP consultation 99213 851
Annual physical exam 99395 413
Vaccination administration 90471 1,645
Minor procedure (skin) 17110 2,442

Hizmetler ve fiyatlandırma

HizmetSüreYöntemFiyat
New patient consultation (60m) 60 dk in_clinic|telemed 180.00 EUR
Follow-up consultation (30m) 30 dk in_clinic|telemed|phone 90.00 EUR
Vaccination administration 30 dk in_clinic 540.00 EUR
Minor procedure (skin) 120 dk in_clinic 810.00 EUR

Ofis, ekip ve uygulamada

Amrita Mahal
HEADSHOT
Amrita Mahal in consultation
IN OFFICE
Amrita Mahal with the team
WITH TEAM
Amrita Mahal at a conference
CONFERENCE

Videolar

introduction · 90s
Meet Amrita Mahal

Araştırma ve yayınlar

h-endeksi: 14 · i10: 7

  1. Long-term follow-up of Speech And Language Therapy across GB
    Amrita Mahal, et al. · European Journal of Medicine, 2026
    DOI: 10.8090/euroclin.2026.0 · PMID: 31092290 · alıntılayan 75
  2. Validation of clinical scoring in Speech And Language Therapy
    Amrita Mahal, et al. · European Journal of Medicine, 2025
    DOI: 10.3771/euroclin.2025.1 · PMID: 33229086 · alıntılayan 33
  3. Long-term follow-up of Speech And Language Therapy across GB
    Amrita Mahal, et al. · European Journal of Medicine, 2024
    DOI: 10.8146/euroclin.2024.2 · PMID: 33850371 · alıntılayan 111
  4. Validation of clinical scoring in Speech And Language Therapy
    Amrita Mahal, et al. · European Journal of Medicine, 2023
    DOI: 10.1786/euroclin.2023.3 · PMID: 34890613 · alıntılayan 141

Davetli konuşmalar

  • Practical updates in Speech And Language Therapy European Annual Congress (Speech And Language Therapy) · Vienna · 2024 · invited
  • Single-centre experience in Speech And Language Therapy National Society Meeting · · 2023 · oral abstract

Ödüller ve üyelikler

Ödüller

  • 🏆 Top-rated Speech And Language Therapy — · EuroClinics Patient Choice · 2025 · regional

Topluluk üyelikleri

  • WONCA Europe — Family Doctors — Member · 2025 yılından beri
  • national college of family doctors — Member · 2025 yılından beri
  • European Union of Medical Specialists (UEMS) — Member · 2025 yılından beri

Bu doktorun makaleleri

  • Patient education Patient guide to Speech And Language Therapy
  • Awareness When should you see a speech and language therapy?

Uluslararası hastalar için

Koordinatör
Patient liaison · amrita.mahal@euroclinics.example

Hasta yorumları

Deneyiminizi paylaşın — diğer hastaların doğru doktoru bulmasına yardımcı olun. Yorum yaz →
20 – 4.000 karakter

Gönderiler moderasyondan geçer ve herkese açık olarak görünmesi 24-72 saat sürebilir. Hastayı tanımlayan bilgiler dahil edilmemelidir.

Son yorumlar

  • ★★★★★ ✓ Doğrulanmış
    Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
    Anna B.
  • ★★★★★ ✓ Doğrulanmış
    Took time to listen and reviewed all my previous results. I would absolutely recommend.
    Marco V.
  • ★★★★☆ ✓ Doğrulanmış
    Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
    Helena F.

Benzer uzmanlar

Tümünü gözat →